Kanya Rajangam

Company: Senti Biosciences Inc.

Job title: President, Head of Research & Development & Chief Medical Officer

Seminars:

Industry Leaders’ Fireside Chat: Achieving Allogeneic Product Success by Aligning Innovation with Investor Expectations 8:10 am

An interactive panel discussion from the industry leaders of the field to set the scene on the allogeneic cell therapy space.  Ask your questions live to understand the expert’s thoughts on key topics including: Evaluating key success factors for allogeneic therapies and how they differ from autologous approaches Discussing the role of clinical trial outcomes…Read more

day: Conference Day One

Highlighting Key Clinical Readouts in the Application of NK Cells to Haematological Malignancies to Further NK Therapy Development 10:00 am

Discussing key successes thus far in clinic of Senti-202 in AML Sharing lessons learned and next stepsRead more

day: Conference Day One